At M&A Healthcare Advisors, we closely monitor regulatory changes that influence transaction strategy and valuation in the healthcare sector. In
Press
Press
At M&A Healthcare Advisors, we closely monitor regulatory changes that influence transaction strategy and valuation in the healthcare sector. In
In the aftermath of Walmart's decision to discontinue its health and virtual care delivery products, Andre Ulloa, Founder and Executive
Ulloa suggests that the current environment poses challenges for deal-making, with regulatory headwinds impacting M&A activity… This environment of heightened
As the healthcare landscape continues to evolve, new regulations often present challenges for M&A activity within the industry. The 36-month
“We haven’t seen much private equity activity in the last year or so, only because there’s been a lot of
“They don’t have the leadership or the proper strategy for growth, and now there’s just too much pressure being put
“The reason that the Optum deal is more attractive, other than it being a better price, is because Optum is
The recent disclosure of the merger between home health and hospice provider Amedisys and infusion services provider Option Care Health
Andre Ulloa, partner at M&A Healthcare Advisors, was featured in McKnights Home Care article on the current state of the
Andre Ulloa, partner at M&A Healthcare Advisors, was featured in McKnights Home Care article on CVS’ acquisition of Signify. On